Max Healthcare enters into partnership with Anuva

27 Dec 2022 Evaluate

Max Healthcare Institute has entered into a partnership with genomics biotech firm Anuva to conduct genomic-based research on various communicable and non-communicable diseases in India. The two partners have signed a Memorandum of Understanding (MoU) for a five-year engagement.

The objective of the research will be to identify insights for precision medicine application across diseases including breast cancer, lung cancer, diabetes, cardiac disease, kidney disease, drug resistant tuberculosis, and others. Under the collaboration, Max Healthcare will provide its expertise in clinical research and will serve as the clinical centre for data and/or sample collection from individuals who consent to share their data for the purpose of research.

Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda.

Max Healthcare Inst Share Price

820.95 37.55 (4.79%)
05-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 337.30
Apollo Hospital Ent. 5915.80
Max Healthcare Inst 820.95
Narayana Hrudayalay 1192.00
Global Health 1115.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.